IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q3 2019 Holdings

Filed 2019-11-14 | 10 holdings | $21.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$21.8M1,915,27499.5%
Misonix, Inc.(MSON)COM604871103$34.1K1,695,9690.2%
Avrobio IncCOM05455M100$20.0K1,417,2040.1%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$19.9K1,719,5760.1%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$18.4K542,1430.1%
Sutro Biopharma IncCOM869367102$16.6K1,824,5420.1%
Transenterix IncCOM NEW89366M201$4.1K6,631,8320.0%
X4 Pharmaceuticals Inc(ASNSUSD)COM98420X103$4.0K311,4900.0%
Ocular Therapeutix Inc(OCUL)COM67576A100$1.9K628,2360.0%
Catabasis Pharmaceuticals in(CATBEUR)COM NEW14875P206$1.5K285,7650.0%